Over 70 million Americans wear digital activity trackers (DATs) to record their sleep, steps and heart rate. A new study from ...

Prescription stimulants are among the most widely used psychiatric medications in the world. For decades, the prevailing medical consensus held that drugs like methylphenidate treat attention deficit ...

A quick sitting-rising test reveals surprising insights into your health and longevity, measuring strength, balance, and ...

Oveporexton, a novel first-in-class OX2R-selective agonist, shows promise for improving memory, attention, and executive function in individuals with narcolepsy type 1.

The findings challenge the conventional view that daytime sleepiness is always a result of insufficient sleep, poor sleep hygiene or classic sleep disorders. Instead, they suggest that internal ...

Dominant baboons sleep less at night, as social rank keeps leaders more alert and prone to nighttime disruptions.

As rates of obesity, high blood pressure, type 2 diabetes and sleep apnea increase, cases of advanced chronic liver disease ...

Huxley Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and commercial release of central sleep apnea (CSA) detection for its SANSA(R) home sleep apnea test.

Elite athletes find cannabidiol, or CBD, useful for soreness and recovery, a new study shows. Researchers found that top ...

Background Few studies have investigated patient-reported non-motor outcomes after stroke in young adults. We aimed to assess ...

Recent research highlights complex links between exposure to heat across the seasons and symptoms of depression and mania.